Skip to main content
Equibles
TMDX logo

TMDX · TransMedics Group, Inc. · Analyst Estimates

Track TMDX — free

Use TMDX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TMDX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$65.99 -1.13 (-1.68%) At close · Oct 30 Q1 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.29B
Shares
34.68M
Volume · Oct 30 900.11K Avg daily vol (3M) 835.12K

Analyst Estimates

Compare analyst forecasts for TransMedics Group, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-24 22:55 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.17
1.51
1.63
10
1.51
1.52
1.56
1.76
1
3
0
0
Revenue
USD
Publication date not stated
727.50M
742.18M
753.00M
13
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.61
2.25
3.04
10
2.25
2.28
2.31
2.86
1
2
0
0
Revenue
USD
Publication date not stated
859.40M
874.68M
915.00M
12
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.15
0.29
0.40
10
0.29
0.29
0.30
0.39
1
2
0
0
Revenue
USD
Publication date not stated
169.90M
178.05M
188.45M
12
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.31
0.50
0.57
9
0.50
0.50
0.53
0.60
1
2
0
0
Revenue
USD
Publication date not stated
195.00M
201.27M
206.70M
11
 — — — — — — — —
Key facts CIK 1756262 CUSIP 89377M109 13F (30d) 121 filings 110 filers Visit website Investor relations